Related Experiment Video
Updated: May 2, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Real-time cellular analysis for quantitative detection of functional Clostridium difficile toxin in stool
Bin Huang1, Haijing Li, Dazhi Jin
1Department of Laboratory Medicine, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
A new real-time cellular analysis (RTCA) assay offers rapid and accurate diagnosis of Clostridium difficile infection (CDI). This electronic impedance-based method aids in monitoring disease severity and treatment effectiveness.
Area of Science:
- Microbiology
- Biomedical Engineering
- Infectious Diseases
Background:
- Clostridium difficile infection (CDI) diagnosis and monitoring are critical for patient care and infection control.
- Current laboratory techniques for CDI diagnosis require improvement in speed and accuracy.
- There is a need for novel diagnostic tools to assess CDI severity and therapeutic response.
Purpose of the Study:
- To introduce and evaluate a real-time cellular analysis (RTCA) assay for diagnosing and monitoring CDI.
- To demonstrate the utility of RTCA in detecting C. difficile functional toxin directly from stool specimens.
- To compare the RTCA assay with conventional and molecular diagnostic methods.
Main Methods:
- The RTCA assay utilizes electronic impedance measurements to detect physiological changes in cells.
- Cells are cultured on gold microelectrodes in microtiter wells to monitor impedance.
- The assay was adapted for quantitative detection of C. difficile functional toxin in stool samples.
Main Results:
- The RTCA assay demonstrated quantitative detection of C. difficile functional toxin.
- The assay measures minute physiological changes in cells, indicating infection presence.
- RTCA offers a valuable tool for CDI diagnosis and monitoring.
Conclusions:
- The RTCA assay provides a rapid and accurate method for CDI diagnosis.
- This assay can assess clinical severity and monitor therapeutic efficacies in CDI patients.
- RTCA represents a significant advancement over conventional and molecular diagnostic techniques for CDI.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016